We examine the effects of MD–Value in Prevention (MDVIP) enrollment on Medicare expenditures and utilization among fee-for-service beneficiaries with diabetes over a 5-year period.
Lisa Tomai, MS
Advertisement
Articles by Lisa Tomai, MS
Advertisement
Latest Updated Articles
- Payer Effects of Personalized Preventive Care for Patients With Diabetes
Published: March 6th 2020 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Tirzepatide Plus Hormone Therapy Boosts Weight Loss in Menopause: Regina Castaneda, MD
2
Digital, Blood-Based Innovations Transform Alzheimer Disease Detection: Ken Cohen, MD, FACP
3
Elinzanetant Shows Consistent Efficacy, Safety, and Sleep Benefits Across Studies
4
FDA Approves Elinzanetant, a Hormone-Free Option for Hot Flashes in Menopause
5
